---
$id: https://graph.org.ai/products/commodity/51241206
$type: Product
source: UNSPSC
code: "51241206"
title: "Chloroxine"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Chloroxine

**UNSPSC Code**: 51241206
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-psoriatic agent with the molecular formula C9H5Cl2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2I8BD50I8B, chemically known as 5,7-dichloroxine but generally known as chloroxine, which bears US NIH Compound Identifier 2722. European Medicines Agency schedules Chloroxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13339MIG. As of Q4 2014, CHLOROXINE remains the US FDA Preferred Term for this commodity. Chloroxine bears US NLM identifiers UMLS ID C0055461 and NCI Concept Code C47446. SMILES: CLC1C2C(NCCC2)C(O)C(CL)C1.

